Skip to main content

Table 1 Heart failure occurring after initiation of hormone replacement therapy for Addison’s disease

From: Takotsubo-like syndrome triggered by fludrocortisone overdose for Addison’s disease: a case report

Reference

Age/Sex

Comorbidity

Therapy

Onset of heart failure after

Left ventricular function

Left ventricular function normal after

Acute electrocardiogram

Follow-up electrocardiogram

Heart failure therapy

Outcome

2

47/f

None

HC, FC

20 days

Normal, pericardial effusion

4 months

Normal

NR

Furosemide

R

3

11/m

None

HC

1 day

Severely reduced

6 months

VT

NR

Catecholamines, furosemide

R

4

68/m

Mitral valve prosthesis, hepatopathy

Cortone (cortisone)

4 years

NR

NR

NR

NR

Furosemide, nitrates

R

5

71/f

None

HC

Shortly

Apical ballooning

9 months

ST↑

NR

ß-Blocker, ACE-inhibitor

R

6

69/f

Pyelonephritis

HC

3 days

Severely reduced

3 weeks

T-Inv, QT→, VT

Regression of T-Inv

Cardioversion

NR

7

6/m

None

HC, FC

20 days

Severely reduced

7 days

NR

NR

Furosemide, spironolactone

R

8

42/f

None

HC

2 days

Severely reduced

7 days

ST↑

Normal after 1 week

Catecholamines, mech vent

R

9

53/f

Thyroiditis

HC

Several days

Apical ballooning

2 weeks

ST↑, T-Inv, QT→

NR

NR

R

Present case

41/f

Thyroiditis

HC, FC

3 weeks

Severely reduced

3 months

T-Inv, QT→

ST abnormality

ß-Blocker, ACE-inhibitor, furosemide

R

  1. ACE angiotensin-converting enzyme, f female, FC fludrocortisone, HC hydrocortisone, m male, mech vent mechanical ventilation, NR not reported, QT→ QT prolongation, R recovered, ST↑ ST segment elevation, T-Inv T-wave inversion, VT ventricular tachycardia